Page 44 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 2
152.El-Gabalawy HS, Robinson DB, Smolik I, et al. Familial clustering of the serum cytokine pro- file in the relatives of rheumatoid arthritis patients. Arthritis Rheum 2012;64(6):1720–9. 153.Hughes-Austin JM, DeaneKD, Derber LA, etal.Multiplecytokinesand chemokines are as- sociated with rheumatoid arthritis-related autoimmunity in first-degree relatives with- out rheumatoid arthritis: studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann
Rheum Dis 2013;72(6):901–7.
154.Jorgensen KT, Wiik A, Pedersen M, et al. Cytokines, autoantibodies and viral antibodies in
premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control
study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008;67(6):860–6. 155.Karlson EW, Chibnik LB, Tworoger SS, et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum
2009;60(3):641–52.
156.Limper M, van de Stadt L, Bos W, et al. The acute-phase response is not predictive for
the development of arthritis in seropositive arthralgia - a prospective cohort study. J
Rheumatol 2012;39(10):1914–7.
157.Masi AT, Aldag JC, Sipes J. Do elevated levels of serum C-reactive protein predict rheuma-
toid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid
factors. J Rheumatol 2001;28(10):2359–61.
158.Nielen MM, van SD, Reesink HW, et al. Increased levels of C-reactive protein in se-
rum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum
2004;50(8):2423–7.
159.Rantapaa-Dahlqvist S, Boman K, Tarkowski A, et al. Up regulation of monocyte chemoat-
tractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheuma- toid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis 2007; 66(1):121–3.
160.Sokolove J, Bromberg R, Deane KD, et al. Autoantibody epitope spreading in the pre-clin- ical phase predicts progression to rheumatoid arthritis. PLoS One 2012;7(5):e35296. 161.Turesson C, Bergstrom U, Jacobsson LT, et al. Increased cartilage turnover and circulating
autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann
Rheum Dis 2011;70(3):520–2.
162.Woolf AD, Hall ND, Goulding NJ, et al. Predictors of the long-term outcome of early syno-
vitis: a 5-year follow-up study. Br J Rheumatol 1991;30(4):251–4.
163.van Baarsen LG, Wijbrandts CA, Timmer TC, et al. Synovial tissue heterogeneity in rheu-
matoid arthritis in relation to disease activity and biomarkers in peripheral blood. Arthri-
tis Rheum 2010;62(6):1602–7.
164.Lubbers J, Brink M, van de Stadt LA, et al. The type I IFN signature as a biomarker of pre-
clinical rheumatoid arthritis. Ann Rheum Dis 2013;72(5):776–80.
165.van de Stadt LA, Bos WH, Meursinge RM, et al. The value of ultrasonography in pre-
dicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study.
Arthritis Res Ther 2010;12(3):R98.
166.Rakieh C, Nam JL, Hunt L, et al. Predicting the development of clinical arthritis in anti-CCP
positive individuals with non-specific musculoskeletal symptoms: a prospective observa- tional cohort study. Ann Rheum Dis 2014. [Epub ahead of print].
42